Tapewire

NYSE · USD

UNH

UNITEDHEALTH GROUP INC

Export transactions ↓
Tapewire entity
2809
SEC CIK
0000731766
Parsed reports
3,134

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202601
May 202600
Jun 202600
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 23, 2009 Filed Feb 26, 2009 02:46 UTC
Sweere LoriEVP, Human Capital
GrantStock Appreciation Rights · Derivative 56,561 $0.00 Strike: $29.74 $0.00
Disclosure

SEC source: 0000731766-09-000037 · edgardoc.xml · derivative · entry 2

Sweere Lori · CIK 0001407932 · EVP, Human Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,561

Underlying: Common Stock · 56,561 shares

Expires 2019-02-23

F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013.

Read SEC document
February 23, 2009 Filed Feb 26, 2009 02:46 UTC
Sweere LoriEVP, Human Capital
GrantCommon Stock 19,231 $0.00 $0.00
Disclosure

SEC source: 0000731766-09-000037 · edgardoc.xml · nonDerivative · entry 1

Sweere Lori · CIK 0001407932 · EVP, Human Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,625

F1 · security: The restricted stock units will vest at a rate of 25% annually on February 3 from the years 2010 through 2013.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 23, 2009, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of average EPS growth percentanges and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 38,462. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

Read SEC document
February 23, 2009 Filed Feb 26, 2009 02:46 UTC
WELTERS ANTHONYEVP & Pres Publc & Sr Mkts Grp
GrantStock Appreciation Rights · Derivative 113,122 $0.00 Strike: $29.74 $0.00
Disclosure

SEC source: 0000731766-09-000038 · edgardoc.xml · derivative · entry 2

WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,122

Underlying: Common Stock · 113,122 shares

Expires 2019-02-23

F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013.

Read SEC document
February 23, 2009 Filed Feb 26, 2009 02:46 UTC
WELTERS ANTHONYEVP & Pres Publc & Sr Mkts Grp
GrantCommon Stock 38,462 $0.00 $0.00
Disclosure

SEC source: 0000731766-09-000038 · edgardoc.xml · nonDerivative · entry 1

WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,707

F1 · security: The restricted stock units will vest at a rate of 25% annually on February 3 from the years 2010 through 2013.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 23, 2009, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of average EPS growth percentanges and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 76,923. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

Read SEC document
February 23, 2009 Filed Feb 26, 2009 02:46 UTC
WICHMANN DAVID SEVP & Pres, UHG Operations
GrantStock Appreciation Rights · Derivative 113,122 $0.00 Strike: $29.74 $0.00
Disclosure

SEC source: 0000731766-09-000039 · edgardoc.xml · derivative · entry 3

WICHMANN DAVID S · CIK 0001268489 · EVP & Pres, UHG Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,122

Underlying: Common Stock · 113,122 shares

Expires 2019-02-23

F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013.

Read SEC document
February 23, 2009 Filed Feb 26, 2009 02:46 UTC
WICHMANN DAVID SEVP & Pres, UHG Operations
GrantCommon Stock 38,462 $0.00 $0.00
Disclosure

SEC source: 0000731766-09-000039 · edgardoc.xml · nonDerivative · entry 1

WICHMANN DAVID S · CIK 0001268489 · EVP & Pres, UHG Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,600

F1 · security: The restricted stock units will vest at a rate of 25% annually on February 3 from the years 2010 through 2013.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 23, 2009, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of average EPS growth percentanges and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 76,923. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

Read SEC document
February 19, 2009 Filed Feb 19, 2009 23:16 UTC
RANGEN ERIC SSr VP & Chief Acctg Officer
Tax withholdingCommon Stock 2,861 $28.65 $81,967.65
Disclosure

SEC source: 0000731766-09-000023 · edgardoc.xml · nonDerivative · entry 1

RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,160

F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

Read SEC document
February 12, 2009 Filed Feb 13, 2009 21:23 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $7.76 $0.00
Disclosure

SEC source: 0000731766-09-000022 · edgardoc.xml · derivative · entry 11

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2010-04-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents an exercise of stock options where cash was used to pay the exercise price and all shares were retained by Mr. Leatherdale.

Read SEC document
February 12, 2009 Filed Feb 13, 2009 21:23 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $7.61 $0.00
Disclosure

SEC source: 0000731766-09-000022 · edgardoc.xml · derivative · entry 10

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2009-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents an exercise of stock options where cash was used to pay the exercise price and all shares were retained by Mr. Leatherdale.

Read SEC document
February 12, 2009 Filed Feb 13, 2009 21:23 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $6.72 $0.00
Disclosure

SEC source: 0000731766-09-000022 · edgardoc.xml · derivative · entry 9

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2010-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents an exercise of stock options where cash was used to pay the exercise price and all shares were retained by Mr. Leatherdale.

Read SEC document
February 12, 2009 Filed Feb 13, 2009 21:23 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $5.72 $0.00
Disclosure

SEC source: 0000731766-09-000022 · edgardoc.xml · derivative · entry 8

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2009-10-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents an exercise of stock options where cash was used to pay the exercise price and all shares were retained by Mr. Leatherdale.

Read SEC document
February 12, 2009 Filed Feb 13, 2009 21:23 UTC Exercise / conversionCommon Stock 10,000 $7.76 $77,579.00
Disclosure

SEC source: 0000731766-09-000022 · edgardoc.xml · nonDerivative · entry 4

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 939,615

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 12, 2009 Filed Feb 13, 2009 21:23 UTC Exercise / conversionCommon Stock 10,000 $6.72 $67,188.00
Disclosure

SEC source: 0000731766-09-000022 · edgardoc.xml · nonDerivative · entry 3

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 929,615

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 12, 2009 Filed Feb 13, 2009 21:23 UTC Exercise / conversionCommon Stock 10,000 $5.72 $57,188.00
Disclosure

SEC source: 0000731766-09-000022 · edgardoc.xml · nonDerivative · entry 2

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 919,615

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 12, 2009 Filed Feb 13, 2009 21:23 UTC Exercise / conversionCommon Stock 10,000 $7.61 $76,094.00
Disclosure

SEC source: 0000731766-09-000022 · edgardoc.xml · nonDerivative · entry 1

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 909,615

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2009 Filed Feb 9, 2009 11:14 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 4,875,000 $0.00 Strike: $8.72 $0.00
Disclosure

SEC source: 0000731766-09-000021 · edgardoc.xml · derivative · entry 4

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,875,000 shares

Expires 2009-10-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2009 Filed Feb 9, 2009 11:14 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
Tax withholdingCommon Stock 2,919,735 $28.94 $84,497,130.90
Disclosure

SEC source: 0000731766-09-000021 · edgardoc.xml · nonDerivative · entry 2

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,348,339

F1 · shares: Represents a "net exercise" of an aggregate of 4,875,000 stock options where 2,919,735 shares were used to pay the exercise price and taxes, and the remaining net 1,955,265 shares were issued to and retained by Mr. Hemsley.

F2 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

Read SEC document
February 06, 2009 Filed Feb 9, 2009 11:14 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
Exercise / conversionCommon Stock 4,875,000 $8.72 $42,504,150.00
Disclosure

SEC source: 0000731766-09-000021 · edgardoc.xml · nonDerivative · entry 1

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,268,074

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents a "net exercise" of an aggregate of 4,875,000 stock options where 2,919,735 shares were used to pay the exercise price and taxes, and the remaining net 1,955,265 shares were issued to and retained by Mr. Hemsley.

F2 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

Read SEC document
February 05, 2009 Filed Nov 14, 2011 22:02 UTC
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
GiftCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-055795 · doc4.xml · nonDerivative · entry 2

BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Indirect · by 2009-M Annuity Trust

Disclosed balance after: 15,000

Read SEC document
February 05, 2009 Filed Nov 14, 2011 22:02 UTC
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
GiftCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-055795 · doc4.xml · nonDerivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,769.604

Read SEC document
February 03, 2009 Filed Feb 4, 2009 22:35 UTC GrantCommon Stock 440 $0.00 $0.00
Disclosure

SEC source: 0000731766-09-000013 · edgardoc.xml · nonDerivative · entry 1

DARRETTA ROBERT J · CIK 0001188999 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,035

F1 · kind: The reporting person previously elected to convert eligible cash compensation into common stock pursuant to a previously approved policy.

Read SEC document
February 03, 2009 Filed Feb 4, 2009 22:35 UTC GrantCommon Stock 440 $0.00 $0.00
Disclosure

SEC source: 0000731766-09-000014 · edgardoc.xml · nonDerivative · entry 1

HOOPER MICHELE J · CIK 0001201723 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,190

F1 · kind: The reporting person previously elected to convert eligible cash compensation into common stock pursuant to a previously approved policy.

Read SEC document
February 03, 2009 Filed Feb 4, 2009 22:35 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,920 $0.00 Strike: $29.74 $0.00
Disclosure

SEC source: 0000731766-09-000015 · edgardoc.xml · derivative · entry 1

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,920

Underlying: Common Stock · 1,920 shares

Expires 2019-02-03

F1 · kind: The reporting person previously elected to convert eligible cash compensation into stock options pursuant to a previously approved policy.

Read SEC document
February 03, 2009 Filed Feb 4, 2009 22:35 UTC
RENFRO LARRY CEVP, UHG & CEO, Ovations
GrantStock Appreciation Rights · Derivative 92,800 $0.00 Strike: $29.74 $0.00
Disclosure

SEC source: 0000731766-09-000016 · edgardoc.xml · derivative · entry 2

RENFRO LARRY C · CIK 0001235046 · EVP, UHG & CEO, Ovations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,800

Underlying: Common Stock · 92,800 shares

Expires 2019-02-03

F2 · kind: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013.

Read SEC document
February 03, 2009 Filed Feb 4, 2009 22:35 UTC
RENFRO LARRY CEVP, UHG & CEO, Ovations
GrantCommon Stock 106,600 $0.00 $0.00
Disclosure

SEC source: 0000731766-09-000016 · edgardoc.xml · nonDerivative · entry 1

RENFRO LARRY C · CIK 0001235046 · EVP, UHG & CEO, Ovations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,600

F1 · kind: The restricted stock units will vest at a rate of 25% annually on February 3 from the years 2010 through 2013.

Read SEC document
February 03, 2009 Filed Feb 4, 2009 22:35 UTC GrantCommon Stock 440 $0.00 $0.00
Disclosure

SEC source: 0000731766-09-000017 · edgardoc.xml · nonDerivative · entry 1

RENWICK GLENN M · CIK 0001198119 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,735

F1 · kind: The reporting person previously elected to convert eligible cash compensation into common stock pursuant to a previously approved policy.

Read SEC document
February 03, 2009 Filed Feb 4, 2009 22:35 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0000731766-09-000018 · edgardoc.xml · nonDerivative · entry 1

Shine Kenneth Irwin · CIK 0001455025 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,250

F1 · kind: Represents restricted stock units granted to Dr. Shine in connection with his appointment to the Board of Directors of UnitedHealth Group Incorporated. The restricted stock units will vest at a rate of 25% annually on February 3 from the years 2010 through 2013, subject to continued service as a director on the applicable vesting date.

Read SEC document
February 03, 2009 Filed Feb 4, 2009 22:36 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 880 $0.00 Strike: $29.74 $0.00
Disclosure

SEC source: 0000731766-09-000019 · edgardoc.xml · derivative · entry 1

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 880

Underlying: Common Stock · 880 shares

Expires 2019-02-03

F1 · kind: The reporting person previously elected to convert a portion of her eligible cash compensation into stock options pursuant to a previously approved policy.

Read SEC document
January 02, 2009 Filed Jan 5, 2009 23:25 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $27.59 $0.00
Disclosure

SEC source: 0000731766-09-000001 · edgardoc.xml · derivative · entry 1

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2019-01-02

Read SEC document
January 02, 2009 Filed Jan 5, 2009 23:25 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $27.59 $0.00
Disclosure

SEC source: 0000731766-09-000002 · edgardoc.xml · derivative · entry 1

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2019-01-02

Read SEC document
January 02, 2009 Filed Jan 5, 2009 23:25 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $27.59 $0.00
Disclosure

SEC source: 0000731766-09-000003 · edgardoc.xml · derivative · entry 1

DARRETTA ROBERT J · CIK 0001188999 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2019-01-02

Read SEC document
January 02, 2009 Filed Jan 5, 2009 23:25 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $27.59 $0.00
Disclosure

SEC source: 0000731766-09-000004 · edgardoc.xml · derivative · entry 1

HOOPER MICHELE J · CIK 0001201723 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2019-01-02

Read SEC document
January 02, 2009 Filed Jan 5, 2009 23:26 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $27.59 $0.00
Disclosure

SEC source: 0000731766-09-000005 · edgardoc.xml · derivative · entry 1

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2019-01-02

Read SEC document
January 02, 2009 Filed Jan 5, 2009 23:26 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $27.59 $0.00
Disclosure

SEC source: 0000731766-09-000006 · edgardoc.xml · derivative · entry 1

RENWICK GLENN M · CIK 0001198119 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2019-01-02

Read SEC document
January 02, 2009 Filed Jan 5, 2009 23:26 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $27.59 $0.00
Disclosure

SEC source: 0000731766-09-000007 · edgardoc.xml · derivative · entry 1

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2019-01-02

Read SEC document
November 07, 2008 Filed Nov 10, 2008 22:20 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,320 $0.00 Strike: $22.43 $0.00
Disclosure

SEC source: 0000731766-08-000129 · edgardoc.xml · derivative · entry 1

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,320

Underlying: Common Stock · 2,320 shares

Expires 2018-11-07

F1 · kind: The reporting person previously elected to convert eligible cash compensation into stock options pursuant to a previously approved policy.

Read SEC document
November 07, 2008 Filed Nov 10, 2008 22:20 UTC GrantCommon Stock 580 $0.00 $0.00
Disclosure

SEC source: 0000731766-08-000130 · edgardoc.xml · nonDerivative · entry 1

DARRETTA ROBERT J · CIK 0001188999 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,595

F1 · kind: The reporting person previously elected to convert eligible cash compensation into common stock pursuant to a previously approved policy.

Read SEC document
November 07, 2008 Filed Nov 10, 2008 22:21 UTC GrantCommon Stock 580 $0.00 $0.00
Disclosure

SEC source: 0000731766-08-000131 · edgardoc.xml · nonDerivative · entry 1

HOOPER MICHELE J · CIK 0001201723 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,750

F1 · kind: The reporting person previously elected to convert eligible cash compensation into common stock pursuant to a previously approved policy.

Read SEC document
November 07, 2008 Filed Nov 10, 2008 22:21 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,550 $0.00 Strike: $22.43 $0.00
Disclosure

SEC source: 0000731766-08-000132 · edgardoc.xml · derivative · entry 1

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,550

Underlying: Common Stock · 2,550 shares

Expires 2018-11-07

F1 · kind: The reporting person previously elected to convert eligible cash compensation into stock options pursuant to a previously approved policy.

Read SEC document
November 07, 2008 Filed Nov 10, 2008 22:21 UTC GrantCommon Stock 580 $0.00 $0.00
Disclosure

SEC source: 0000731766-08-000133 · edgardoc.xml · nonDerivative · entry 1

RENWICK GLENN M · CIK 0001198119 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,295

F1 · kind: The reporting person previously elected to convert eligible cash compensation into common stock pursuant to a previously approved policy.

Read SEC document
November 07, 2008 Filed Nov 10, 2008 22:21 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 740 $0.00 Strike: $22.43 $0.00
Disclosure

SEC source: 0000731766-08-000134 · edgardoc.xml · derivative · entry 1

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 740

Underlying: Common Stock · 740 shares

Expires 2018-11-07

F1 · kind: The reporting person previously elected to convert a portion of her eligible cash compensation into stock options pursuant to a previously approved policy.

Read SEC document
October 24, 2008 Filed Oct 24, 2008 21:09 UTC
Sweere LoriEVP, Human Capital
PurchaseCommon Stock 1,250 $22.05 $27,558.00
Disclosure

SEC source: 0000731766-08-000128 · edgardoc.xml · nonDerivative · entry 1

Sweere Lori · CIK 0001407932 · EVP, Human Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,394

F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

Read SEC document
October 17, 2008 Filed Oct 20, 2008 21:22 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 150,000 $0.00 Strike: $8.72 $0.00
Disclosure

SEC source: 0000731766-08-000127 · edgardoc.xml · derivative · entry 3

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,875,000

Underlying: Common Stock · 150,000 shares

Expires 2009-10-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 17, 2008 Filed Oct 20, 2008 21:22 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
Exercise / conversionCommon Stock 150,000 $8.72 $1,307,820.00
Disclosure

SEC source: 0000731766-08-000127 · edgardoc.xml · nonDerivative · entry 1

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 393,074

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

Read SEC document
October 01, 2008 Filed Oct 2, 2008 22:23 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $25.08 $0.00
Disclosure

SEC source: 0000731766-08-000120 · edgardoc.xml · derivative · entry 1

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2018-10-01

Read SEC document
October 01, 2008 Filed Oct 2, 2008 22:24 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $25.08 $0.00
Disclosure

SEC source: 0000731766-08-000121 · edgardoc.xml · derivative · entry 1

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2018-10-01

Read SEC document
October 01, 2008 Filed Oct 2, 2008 22:24 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $25.08 $0.00
Disclosure

SEC source: 0000731766-08-000122 · edgardoc.xml · derivative · entry 1

DARRETTA ROBERT J · CIK 0001188999 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2018-10-01

Read SEC document
October 01, 2008 Filed Oct 2, 2008 22:24 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $25.08 $0.00
Disclosure

SEC source: 0000731766-08-000123 · edgardoc.xml · derivative · entry 1

HOOPER MICHELE J · CIK 0001201723 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2018-10-01

Read SEC document
October 01, 2008 Filed Oct 2, 2008 22:24 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $25.08 $0.00
Disclosure

SEC source: 0000731766-08-000124 · edgardoc.xml · derivative · entry 1

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2018-10-01

Read SEC document
October 01, 2008 Filed Oct 2, 2008 22:24 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $25.08 $0.00
Disclosure

SEC source: 0000731766-08-000125 · edgardoc.xml · derivative · entry 1

RENWICK GLENN M · CIK 0001198119 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2018-10-01

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.